Radiotherapy & Oncology
Volume 94, Issue 2 , Pages 173-180 , February 2010

From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer

Received 4 November 2009 ,Revised 4 January 2010 ,Accepted 7 January 2010.

References 

  1. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:901–911
  2. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Pötter R. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol. 2003;68:51–59
  3. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74:235–245
  4. Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78:67–77
  5. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71:756–764
  6. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van LE. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol. 2008;88:217–226
  7. Chargari C, Magne N, Dumas I, et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. Int J Radiat Oncol Biol Phys. 2009;74:133–139
  8. Jurgenliemk-Schulz IM, Tersteeg RJ, Roesink JM, et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol. 2009;93:322–330
  9. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magne N. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Radiother Oncol. 2009;93:316–321
  10. Dimopoulos JC, De V, Berger D, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol. 2009;91:166–172
  11. Petric P, Dimopoulos J, Kirisits C, Berger D, Hudej R, Pötter R. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol. 2008;89:164–171
  12. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491–498
  13. Tanderup K, Hellebust TP, Lang S, et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol. 2008;89:156–163
  14. Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol. 2009;91:187–193
  15. de Leeuw AA, Moerland MA, Nomden C, Tersteeg RH, Roesink JM, Jurgenliemk-Schulz IM. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. Radiother Oncol. 2009;93:341–346
  16. Berger D, Dimopoulos J, Potter R, Kirisits C. Direct reconstruction of the Vienna applicator on MR images. Radiother Oncol. 2009;93:347–351
  17. Perez-Calatayud J, Kuipers F, Ballester F, et al. Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning. Radiother Oncol. 2009;91:181–186
  18. Wills R, Lowe G, Inchley D, Anderson C, Beenstock V, Hoskin P. Applicator reconstruction for HDR cervix treatment planning using images from 0.35T open MR scanner. Radiother Oncol 2009; doi:10.1016/j.radonc.2009.10.015.
  19. Jurgenliemk-Schulz IM, Lang S, Tanderup K, et al. Variation of treatment planning parameters (D90 HR-CTV, D(2cc) for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose–volume constraints. Radiother Oncol 2009; doi:10.1016/j.radonc.2009.10.011.
  20. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65:624–630
  21. Chajon E, Dumas I, Touleimat M, et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys. 2007;69:955–961
  22. Pötter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol. 2007;83:148–155
  23. Petric P, Hudej R, Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachyther. 2009;1:163–169
  24. Lang S, Kirisits C, Dimopoulos J, Georg D, Potter R. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys. 2007;69:619–627
  25. Potish RA, Deibel FC, Khan FM. The relationship between milligram-hours and dose to point A in carcinoma of the cervix. Radiology. 1982;145:479–483
  26. Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E. The GEC ESTRO Handbook of Brachytherapy. Brussels: E; 2007;
  27. Tod M, Meredith WJ. Treatment of cancer of the cervix uteri, a revised Manchester method. Br J Radiol. 1953;26:252–257
  28. Tanderup K, Georg D, Pötter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy, seminars in radiation oncology. Semin Radiat Oncol 2009; doi:10.1016/j.semradonc.2009.11.006.
  29. Mayr NA, Wang JZ, Lo SS, et al. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer. Int J Radiat Oncol Biol Phys 2009; doi:10.1016/j.ijrabp.2009.02.036.
  30. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005;62:131–137
  31. Kim RY, Shen S, Duan J. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose–volume histograms of the bladder, rectum, sigmoid colon, and small bowel. Brachytherapy. 2007;6:187–194
  32. Wang B, Kwon A, Zhu Y, Yeo I, Henson CF. Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning. Brachytherapy. 2009;8:240–247
  33. Dimopoulos JC, Lang S, Kirisits C, et al. Dose–volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2009;75:56–63
  34. Dimopoulos JC, Potter R, Lang S, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol. 2009;93:311–315
  35. Georg P, Kirisits C, Goldner G, et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol. 2009;91:173–180
  36. Koom WS, Sohn DK, Kim JY, et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose–volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys. 2007;68:1446–1454

PII: S0167-8140(10)00020-4

doi: 10.1016/j.radonc.2010.01.001

Radiotherapy & Oncology
Volume 94, Issue 2 , Pages 173-180 , February 2010

Article Tools

* Image Usage & Resolution